The second consensus conference in 2008 suggested directions for research to improve management of patients with atrial fibrillation. Attendees called for research initiatives aiming a better understanding of the different causes of atrial fibrillation and its complications, and at development and validation of mechanism-based therapies. For future therapy they envisioned a combination of management of underlying and concomitant conditions, early and comprehensive rhythm control therapy, adequate control of ventricular rate and cardiac function, and continuous therapy to prevent AF-associated complications. A few years later, AFNET tested this concept in the EAST – AFNET 4 trial.

Scientific Committee:
Angelo Auricchio
Günter Breithardt
Paulus Kirchhof
Silvia Priori  

Program

Publication